🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A double-blind, randomized, placebo-controlled, crossover design trial was ...
Status
Terminated
Location
Boston University Psychiatry Research Center, Clinical Studies Unit
Start Date
2019-05-02
Trial ID
NCT03645408
Treatments Being Tested
Compare the effect of exenatide (therapeutic and supratherapeutic concentra...
Status
Completed
Location
Research Site
Start Date
2011-02
Trial ID
NCT01297062
Treatments Being Tested
The study examines the Safety and efficacy study of exenatide once weekly i...
Status
Completed
Location
Research Site
Start Date
2011-12-02
Trial ID
NCT01554618
Treatments Being Tested
This study aims to assess the effect of exenatide on myocardial injury in p...
Status
Unknown
Location
Foothills Medical Centre
Start Date
2014-02
Trial ID
NCT01938235
The purpose of this study is to investigate the safety and effectiveness of...
Status
Terminated
Location
Orange County Research Center
Start Date
2013-12
Trial ID
NCT02020616
Treatments Being Tested
To compare the effect on glycemic control (HbA1c) of exenatide suspension a...
Status
Completed
Location
Research Site
Start Date
2013-02
Trial ID
NCT01652729
Treatments Being Tested
This is a prospective study to evaluate effect of Exenatide extended releas...
Status
Terminated
Location
Diabetes Endocrinology Research Center of WNY
Start Date
2017-01-10
Trial ID
NCT03029351
Treatments Being Tested
Extreme pediatric obesity, the fastest growing category of obesity in youth...
Status
Completed
Location
University of Minnesota
Start Date
2010-10
Trial ID
NCT01237197
This study is a placebo-controlled study in both healthy normal subjects an...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00259896
Treatments Being Tested
This Phase I clinical study is to evaluate the safety and tolerance of DA-3...
Status
Completed
Location
Clinical Trial center, Clinical Research institute, Seoul National University Hospital
Start Date
2010-07
Trial ID
NCT01156779
Treatments Being Tested